Hindustan Bio Sciences Ka Q3 Result Dhamakedar! Revenue **5320%** Upar, Loss Se Nikal Kar Profit Mein Company!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Hindustan Bio Sciences Ka Q3 Result Dhamakedar! Revenue **5320%** Upar, Loss Se Nikal Kar Profit Mein Company!
Overview

Arre yaar, Hindustan Bio Sciences ne Q3 FY26 mein toh kamaal hi kar diya! Revenue seedha **5320%** upar bhaga, **₹3825 Lakhs** tak pahunch gaya, aur pichhle saal ke loss ko hara kar company **₹8.20 Lakhs** ka profit le aayi.

Achanak kya hua?

Toh bhai, Hindustan Bio Sciences ne apne Q3 FY26 ke numbers reveal kiye hain aur sab chaunk gaye! Quarter-on-quarter agar dekho toh operational revenue 5320% ka ekdum toofani jump maarke ₹3825 Lakhs par pahunch gaya, jo pichhle saal sirf ₹70.44 Lakhs tha. Aur is quarter mein company ne ₹8.20 Lakhs ka net profit bhi kama liya, jabki pichhle saal isi time ₹4.14 Lakhs ka loss tha. Isme ek bada hissa ₹178 Lakhs ka 'Other Income' ka bhi hai, jisne total revenue ko ₹4003 Lakhs bana diya.

Par 9 Mahine Ka Sach Kya Hai?

Ab agar aap long-term picture dekho, matlab 9 mahine (9M FY26) ka hisaab, toh kahani thodi alag hai. Operational revenue actually 48.07% gir kar ₹42.20 Lakhs ho gaya hai, jo pichhle saal ₹81.33 Lakhs tha. Haan, profit toh hai (₹8.20 Lakhs vs ₹0.98 Lakhs loss), par yeh kaise hua, yeh ek bada sawaal hai.

Sawal 'Other Income' Par Hai!

Asal mein, Q3 ka profit ₹8.20 Lakhs mostly ₹178 Lakhs ke 'Other Income' ki wajah se lag raha hai, jabki company ka core business 9 mahine mein 48.07% kam ho gaya hai. Company management ne is baare mein koi zyada detail nahi di hai, na hi koi aage ka outlook bataya hai. Toh yeh jo fayda dikh raha hai, yeh kitna tikega, yeh sabko jaan na hai.

Aage Kya?

Isliye, investors ko zara sabak seekh kar chalna hoga. Jab tak company yeh explain nahi karti ki yeh 'Other Income' ka source kya hai aur operational revenue ko kaise improve karegi, tab tak filhaal ki positive numbers ko cautiously lena chahiye.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.